NodThera to Participate in Cantor Global Healthcare Conference
September 2, 2026
Boston, MA, September 2, 2026 – NodThera, a leading clinical-stage company developing a portfolio of potentially best-in-class brain-penetrant oral NLRP3 inhibitors to address inflammatory drivers